Close

GlaxoSmithKline plc (GSK), Genmab Report PROLONG Phase III Met Primary Endpoint

July 31, 2014 2:52 PM EDT Send to a Friend
GlaxoSmithKline plc (NYSE: GSK) and Genmab A/Sannounced ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login